No more MobilePay on Apple Watches or older phones

MobilePay is weeding out older phones when it comes to future support

If you own an iPhone 4 or older iPhone models, soon you won’t be able to use the Danske Bank-owned MobilePay system any more.

This also applies to Samsung’s Galaxy S3 or older S models, reports Computerworld.

No more support
MobilePay is no longer supporting the Android 4.4 to Android 4.4.4 and iOS 9 operating systems, so a number of mobile phones won’t be able to use the app to send or receive money.

READ ALSO: MobilePay wants to be Denmark’s choice for paying monthly bills

The same goes for anyone with an Apple Watch. The reason given for the latter is that the app has been troublesome for some time now.

Although owned and developed by Danske Bank, MobilePay has been distributed in co-operation with most of the banks in Denmark.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.